ELEKTRA Trial Completes Enrollment to Test Soticlestat in Children With Dravet and LGS
The ELEKTRA clinical trial assessing the investigational oral therapy soticlestat (OV935/TAK-935) in children with Dravet syndrome and Lennox-Gastaut syndrome (LGS) has completed patient enrollment, Ovid Therapeutics recently announced. “We completed enrollment significantly ahead of schedule in our placebo-controlled Phase 2 ELEKTRA…